Item 1. Financial Statements
109K characters. Original on sec.gov ·
Item 1. Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
| September 30, 2025 | December 31, 2024 | |||||||
|---|---|---|---|---|---|---|---|---|
| (in millions, except for share and per share data) | ||||||||
| ASSETS: | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 2,107.9 | $ | 291.2 | ||||
| Accounts receivable, net of allowance for doubtful accounts of $33.9 and $22.5, respectively | 436.8 | 434.4 | ||||||
| Prepaid expenses | 85.2 | 72.8 | ||||||
| Income taxes receivable | 35.8 | 83.3 | ||||||
| Other current assets | 29.4 | 29.9 | ||||||
| Total current assets | 2,695.1 | 911.6 | ||||||
| Noncurrent assets: | ||||||||
| Fixed assets, net | 591.0 | 605.9 | ||||||
| Operating lease right-of-use assets, net | 143.9 | 156.0 | ||||||
| Intangible assets, net | 447.6 | 392.4 | ||||||
| Goodwill | 1,878.6 | 1,726.6 | ||||||
| Deferred income tax assets | 36.7 | 34.3 | ||||||
| Other noncurrent assets | 449.0 | 437.9 | ||||||
| Total assets | $ | 6,241.9 | $ | 4,264.7 | ||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY: | ||||||||
| Current liabilities: | ||||||||
| Accounts payable and accrued liabilities | $ | 229.2 | $ | 249.8 | ||||
| Short-term debt and current portion of long-term debt | 1,488.9 | 514.2 | ||||||
| Deferred revenues | 505.0 | 447.2 | ||||||
| Operating lease liabilities | 26.7 | 26.0 | ||||||
| Income taxes payable | 9.2 | 1.7 | ||||||
| Total current liabilities | 2,259.0 | 1,238.9 | ||||||
| Noncurrent liabilities: | ||||||||
| Long-term debt | 3,229.2 | 2,546.9 | ||||||
| Deferred income tax liabilities | 209.8 | 191.6 | ||||||
| Operating lease liabilities | 144.0 | 158.7 | ||||||
| Other noncurrent liabilities | 22.4 | 23.6 | ||||||
| Total liabilities | 5,864.4 | 4,159.7 | ||||||
| Commitments and contingencies (Note 16) | ||||||||
| Stockholders’ equity: | ||||||||
| Common stock, $.001 par value; 2,000,000,000 shares authorized; 544,003,038 shares issued; 139,370,402 and 140,414,637 shares outstanding, respectively | 0.1 | 0.1 | ||||||
| Additional paid-in capital | 3,095.8 | 2,994.0 | ||||||
| Treasury stock, at cost, 404,632,636 and 403,588,401 shares, respectively | (10,497.0 | ) | (10,062.4 | ) | ||||
| Retained earnings | 7,675.9 | 7,153.4 | ||||||
| Accumulated other comprehensive income | 101.9 | 15.0 | ||||||
| Total Verisk stockholders' equity | 376.7 | 100.1 | ||||||
| Noncontrolling interests | 0.8 | 4.9 | ||||||
| Total stockholders’ equity | 377.5 | 105.0 | ||||||
| Total liabilities and stockholders’ equity | $ | 6,241.9 | $ | 4,264.7 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| (in millions, except for share and per share data) | ||||||||||||||||
| Revenues | $ | 768.3 | $ | 725.3 | $ | 2,293.9 | $ | 2,146.1 | ||||||||
| Operating expenses: | ||||||||||||||||
| Cost of revenues (exclusive of items shown separately below) | 229.5 | 223.4 | 689.8 | 670.6 | ||||||||||||
| Selling, general and administrative | 110.6 | 114.0 | 326.0 | 308.4 | ||||||||||||
| Depreciation and amortization of fixed assets | 64.0 | 58.1 | 197.4 | 174.5 | ||||||||||||
| Amortization of intangible assets | 18.3 | 18.3 | 50.4 | 55.0 | ||||||||||||
| Total operating expenses, net | 422.4 | 413.8 | 1,263.6 | 1,208.5 | ||||||||||||
| Operating income | 345.9 | 311.5 | 1,030.3 | 937.6 | ||||||||||||
| Other (expense) income: | ||||||||||||||||
| Net gain on early extinguishment of debt | — | — | — | 3.6 | ||||||||||||
| Investment (loss) gain | (1.6 | ) | 5.9 | 10.1 | 102.4 | |||||||||||
| Interest expense, net | (42.2 | ) | (32.1 | ) | (114.0 | ) | (90.1 | ) | ||||||||
| Total other (expense) income, net | (43.8 | ) | (26.2 | ) | (103.9 | ) | 15.9 | |||||||||
| Income before income taxes | 302.1 | 285.3 | 926.4 | 953.5 | ||||||||||||
| Provision for income taxes | (76.6 | ) | (65.3 | ) | (215.3 | ) | (206.3 | ) | ||||||||
| Net income | 225.5 | 220.0 | 711.1 | 747.2 | ||||||||||||
| Less: Net loss attributable to noncontrolling interests | — | 0.1 | — | 0.6 | ||||||||||||
| Net income attributable to Verisk | $ | 225.5 | $ | 220.1 | $ | 711.1 | $ | 747.8 | ||||||||
| Basic net income per share attributable to Verisk: | $ | 1.62 | $ | 1.55 | $ | 5.08 | $ | 5.24 | ||||||||
| Diluted net income per share attributable to Verisk: | $ | 1.61 | $ | 1.54 | $ | 5.06 | $ | 5.22 | ||||||||
| Weighted-average shares outstanding: | ||||||||||||||||
| Basic | 139,509,985 | 141,778,551 | 139,874,142 | 142,594,074 | ||||||||||||
| Diluted | 139,941,935 | 142,511,476 | 140,407,010 | 143,259,411 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| (in millions) | ||||||||||||||||
| Net income | $ | 225.5 | $ | 220.0 | $ | 711.1 | $ | 747.2 | ||||||||
| Other comprehensive (loss) income, net of tax: | ||||||||||||||||
| Foreign currency translation adjustment | (14.9 | ) | 47.1 | 84.4 | 31.4 | |||||||||||
| Pension and postretirement liability adjustment | 1.0 | 0.8 | 2.8 | 2.5 | ||||||||||||
| Total other comprehensive (loss) income | (13.9 | ) | 47.9 | 87.2 | 33.9 | |||||||||||
| Comprehensive income | 211.6 | 267.9 | 798.3 | 781.1 | ||||||||||||
| Less: Comprehensive loss (income) attributable to noncontrolling interests | 0.1 | (0.2 | ) | (0.3 | ) | (1.1 | ) | |||||||||
| Comprehensive income attributable to Verisk | $ | 211.7 | $ | 267.7 | $ | 798.0 | $ | 780.0 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED)
For The Three Months Ended September 30, 2025 and 2024
| Common Stock Issued | Par Value | Additional Paid-in Capital | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Income | Total Verisk Stockholders' Equity | Noncontrolling Interests | Total Stockholders’ Equity | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (in millions, except for share data) | ||||||||||||||||||||||||||||||||||||
| Balance, July 1, 2025 | 544,003,038 | $ | 0.1 | $ | 3,080.3 | $ | (10,397.6 | ) | $ | 7,513.2 | $ | 115.7 | $ | 311.7 | $ | 0.9 | $ | 312.6 | ||||||||||||||||||
| Net income | — | — | — | — | 225.5 | — | 225.5 | — | 225.5 | |||||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — | — | (13.8 | ) | (13.8 | ) | (0.1 | ) | (13.9 | ) | |||||||||||||||||||||||
| Investment in noncontrolling interests | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||
| Common stock dividend (1) | — | — | — | — | (62.8 | ) | — | (62.8 | ) | — | (62.8 | ) | ||||||||||||||||||||||||
| Treasury stock acquired (370,103 shares) | — | — | — | (100.1 | ) | — | — | (100.1 | ) | — | (100.1 | ) | ||||||||||||||||||||||||
| Excise tax associated with share repurchases | — | — | — | (0.4 | ) | — | — | (0.4 | ) | — | (0.4 | ) | ||||||||||||||||||||||||
| Stock options exercised (31,049 shares transferred from treasury stock) | — | — | 3.0 | 0.9 | — | — | 3.9 | — | 3.9 | |||||||||||||||||||||||||||
| Performance share units ("PSU") lapsed | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||
| Restricted stock ("RSAs") lapsed (2,559 shares transferred from treasury stock) | — | — | (0.1 | ) | 0.1 | — | — | — | — | — | ||||||||||||||||||||||||||
| Stock-based compensation expense | — | — | 12.1 | — | — | — | 12.1 | — | 12.1 | |||||||||||||||||||||||||||
| Net share settlement from RSAs and PSUs (1,671 shares withheld for tax settlement) | — | — | (0.5 | ) | — | — | — | (0.5 | ) | — | (0.5 | ) | ||||||||||||||||||||||||
| Other stock issuances (6,063 shares transferred from treasury stock) | — | — | 1.0 | 0.1 | — | — | 1.1 | — | 1.1 | |||||||||||||||||||||||||||
| Balance, September 30, 2025 | 544,003,038 | $ | 0.1 | $ | 3,095.8 | $ | (10,497.0 | ) | $ | 7,675.9 | $ | 101.9 | $ | 376.7 | $ | 0.8 | $ | 377.5 | ||||||||||||||||||
| Balance, July 1, 2024 | 544,003,038 | $ | 0.1 | $ | 2,942.8 | $ | (9,389.2 | ) | $ | 6,833.3 | $ | 43.3 | $ | 430.3 | $ | 5.0 | $ | 435.3 | ||||||||||||||||||
| Net income (loss) | — | — | — | — | 220.1 | — | 220.1 | (0.1 | ) | 220.0 | ||||||||||||||||||||||||||
| Other comprehensive income | — | — | — | — | — | 47.6 | 47.6 | 0.2 | 47.8 | |||||||||||||||||||||||||||
| Investment in noncontrolling interests | — | — | — | — | — | 0.1 | 0.1 | — | 0.1 | |||||||||||||||||||||||||||
| Common stock dividend (1) | — | — | — | — | (55.3 | ) | — | (55.3 | ) | — | (55.3 | ) | ||||||||||||||||||||||||
| Treasury stock acquired (1,371,626 shares) | — | — | 22.5 | (422.7 | ) | — | — | (400.2 | ) | — | (400.2 | ) | ||||||||||||||||||||||||
| Treasury stock shares repurchased not yet settled | — | — | (60.0 | ) | 60.0 | — | — | — | — | — | ||||||||||||||||||||||||||
| Excise tax associated with share repurchases | — | — | — | (2.8 | ) | — | — | (2.8 | ) | — | (2.8 | ) | ||||||||||||||||||||||||
| Stock options exercised (300,026 shares transferred from treasury stock) | — | — | 40.3 | 7.3 | — | — | 47.6 | — | 47.6 | |||||||||||||||||||||||||||
| Restricted stock ("RSAs") lapsed (2,089 shares transferred from treasury stock) | — | — | (0.1 | ) | 0.1 | — | — | — | — | — | ||||||||||||||||||||||||||
| Stock-based compensation expense | — | — | 11.6 | — | — | — | 11.6 | — | 11.6 | |||||||||||||||||||||||||||
| Net share settlement from RSAs (1,652 shares withheld for tax settlement) | — | — | (0.4 | ) | — | — | — | (0.4 | ) | — | (0.4 | ) | ||||||||||||||||||||||||
| Other stock issuances (5,642 shares transferred from treasury stock) | — | — | 1.0 | - | — | — | 1.0 | — | 1.0 | |||||||||||||||||||||||||||
| Balance, September 30, 2024 | 544,003,038 | $ | 0.1 | $ | 2,957.7 | $ | (9,747.3 | ) | $ | 6,998.1 | $ | 91.0 | $ | 299.6 | $ | 5.1 | $ | 304.7 |
(1) Refer to Note 11. Stockholders' Equity for discussion related to quarterly cash dividends declared per share
The accompanying notes are an integral part of these condensed consolidated financial statements.
VERISK ANALYTICS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED)
For The Nine Months Ended September 30, 2025 and 2024
| Common Stock Issued | Par Value | Additional Paid-in Capital | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Income | Total Verisk Stockholders' Equity | Noncontrolling Interests | Total Stockholders’ Equity | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (in millions, except for share data) | ||||||||||||||||||||||||||||||||||||
| Balance, January 1, 2025 | 544,003,038 | $ | 0.1 | $ | 2,994.0 | $ | (10,062.4 | ) | $ | 7,153.4 | $ | 15.0 | $ | 100.1 | $ | 4.9 | $ | 105.0 | ||||||||||||||||||
| Net income | — | — | — | — | 711.1 | — | 711.1 | — | 711.1 | |||||||||||||||||||||||||||
| Other comprehensive income | — | — | — | — | — | 86.9 | 86.9 | 0.3 | 87.2 | |||||||||||||||||||||||||||
| Investment in noncontrolling interests | — | — | (0.7 | ) | — | — | — | (0.7 | ) | (4.4 | ) | (5.1 | ) | |||||||||||||||||||||||
| Common stock dividend (1) | — | — | — | — | (188.6 | ) | — | (188.6 | ) | — | (188.6 | ) | ||||||||||||||||||||||||
| Treasury stock acquired (1,577,262 shares) | — | — | 45.0 | (445.2 | ) | — | — | (400.2 | ) | — | (400.2 | ) | ||||||||||||||||||||||||
| Excise tax associated with share repurchases | — | — | — | (2.9 | ) | — | — | (2.9 | ) | — | (2.9 | ) | ||||||||||||||||||||||||
| Stock options exercised (380,952 shares transferred from treasury stock) | — | — | 41.8 | 9.7 | — | — | 51.5 | — | 51.5 | |||||||||||||||||||||||||||
| PSUs lapsed (63,469 shares transferred from treasury stock) | — | — | (1.6 | ) | 1.6 | — | — | — | — | — | ||||||||||||||||||||||||||
| RSAs lapsed (71,202 shares transferred from treasury stock) | — | — | (1.8 | ) | 1.8 | — | — | — | — | — | ||||||||||||||||||||||||||
| Stock-based compensation expense | — | — | 41.8 | — | — | — | 41.8 | — | 41.8 | |||||||||||||||||||||||||||
| Net share settlement from RSAs and PSUs (91,272 shares withheld for tax settlement) | — | — | (26.0 | ) | — | — | — | (26.0 | ) | — | (26.0 | ) | ||||||||||||||||||||||||
| Other stock issuances (17,404 shares transferred from treasury stock) | — | — | 3.3 | 0.4 | — | — | 3.7 | — | 3.7 | |||||||||||||||||||||||||||
| Balance, September 30, 2025 | 544,003,038 | $ | 0.1 | $ | 3,095.8 | $ | (10,497.0 | ) | $ | 7,675.9 | $ | 101.9 | $ | 376.7 | $ | 0.8 | $ | 377.5 | ||||||||||||||||||
| Balance, January 1, 2024 | 544,003,038 | $ | 0.1 | $ | 2,872.3 | $ | (9,037.5 | ) | $ | 6,416.9 | $ | 58.2 | $ | 310.0 | $ | 12.2 | $ | 322.2 | ||||||||||||||||||
| Net income (loss) | — | — | — | — | 747.8 | — | 747.8 | (0.6 | ) | 747.2 | ||||||||||||||||||||||||||
| Other comprehensive income | — | — | — | — | — | 32.1 | 32.1 | 1.1 | 33.2 | |||||||||||||||||||||||||||
| Investment in noncontrolling interests | — | — | (7.0 | ) | — | — | 0.7 | (6.3 | ) | (7.6 | ) | (13.9 | ) | |||||||||||||||||||||||
| Common stock dividend (1) | — | — | — | — | (166.6 | ) | — | (166.6 | ) | — | (166.6 | ) | ||||||||||||||||||||||||
| Treasury stock acquired (2,895,946 shares) | — | — | 37.5 | (787.9 | ) | — | — | (750.4 | ) | — | (750.4 | ) | ||||||||||||||||||||||||
| Treasury stock shares repurchased not yet settled | — | — | (60.0 | ) | 60.0 | — | — | — | — | — | ||||||||||||||||||||||||||
| Excise tax associated with share repurchases | — | — | — | (4.8 | ) | — | — | (4.8 | ) | — | (4.8 | ) | ||||||||||||||||||||||||
| Stock options exercised (873,272 shares transferred from treasury stock) | — | — | 90.1 | 20.4 | — | — | 110.5 | — | 110.5 | |||||||||||||||||||||||||||
| PSUs lapsed (27,819 shares transferred from treasury stock) | — | — | (0.6 | ) | 0.6 | — | — | — | — | — | ||||||||||||||||||||||||||
| RSAs lapsed (65,351 shares transferred from treasury stock) | — | — | (1.5 | ) | 1.5 | — | — | — | — | — | ||||||||||||||||||||||||||
| Stock-based compensation expense | — | — | 37.2 | — | — | — | 37.2 | — | 37.2 | |||||||||||||||||||||||||||
| Net share settlement from RSAs (54,629 shares withheld for tax settlement) | — | — | (13.0 | ) | — | — | — | (13.0 | ) | — | (13.0 | ) | ||||||||||||||||||||||||
| Other stock issuances (17,520 shares transferred from treasury stock) | — | — | 2.7 | 0.4 | — | — | 3.1 | — | 3.1 | |||||||||||||||||||||||||||
| Balance, September 30, 2024 | 544,003,038 | $ | 0.1 | $ | 2,957.7 | $ | (9,747.3 | ) | $ | 6,998.1 | $ | 91.0 | $ | 299.6 | $ | 5.1 | $ | 304.7 |
(1) Refer to Note 11. Stockholders' Equity for discussion related to quarterly cash dividends declared per share
The accompanying notes are an integral part of these condensed consolidated financial statements.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| (in millions) | ||||||||||||||||
| Cash flows from operating activities: | ||||||||||||||||
| Net income | $ | 225.5 | $ | 220.0 | $ | 711.1 | $ | 747.2 | ||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||||||
| Depreciation and amortization of fixed assets | 64.0 | 58.1 | 197.4 | 174.5 | ||||||||||||
| Amortization of intangible assets | 18.3 | 18.3 | 50.4 | 55.0 | ||||||||||||
| Amortization of debt issuance costs and original issue discount, net of original issue premium | 0.9 | 0.9 | 2.3 | 2.2 | ||||||||||||
| Provision for doubtful accounts | 2.5 | 4.3 | 13.9 | 11.2 | ||||||||||||
| Net gain on early extinguishment of debt | — | — | — | (3.6 | ) | |||||||||||
| Impairment of cost-based investments | — | — | — | 1.0 | ||||||||||||
| Stock-based compensation expense | 12.1 | 11.6 | 41.8 | 37.2 | ||||||||||||
| Net gain upon settlement of investment in non-public companies | — | — | — | (98.3 | ) | |||||||||||
| Deferred income taxes | 29.9 | (8.2 | ) | 10.6 | (26.0 | ) | ||||||||||
| Loss on disposal of fixed assets | — | 7.5 | — | 7.7 | ||||||||||||
| Gain on lease modification | — | (1.9 | ) | — | (1.9 | ) | ||||||||||
| Acquisition related liability adjustment | — | — | (1.6 | ) | — | |||||||||||
| Other operating | 2.9 | — | (8.3 | ) | — | |||||||||||
| Changes in assets and liabilities, net of effects from acquisitions: | ||||||||||||||||
| Accounts receivable | 173.1 | 31.6 | (6.6 | ) | (120.2 | ) | ||||||||||
| Prepaid expenses and other assets | (8.4 | ) | 7.9 | (5.3 | ) | 33.1 | ||||||||||
| Operating lease right-of-use assets, net | 6.6 | 9.5 | 18.0 | 23.2 | ||||||||||||
| Income taxes | (5.0 | ) | (3.5 | ) | 55.5 | 13.8 | ||||||||||
| Accounts payable and accrued liabilities | 54.5 | 32.9 | (14.6 | ) | (66.1 | ) | ||||||||||
| Deferred revenues | (165.3 | ) | (75.7 | ) | 52.8 | 122.2 | ||||||||||
| Operating lease liabilities | (8.3 | ) | (14.9 | ) | (20.4 | ) | (26.7 | ) | ||||||||
| Other liabilities | 0.2 | (2.2 | ) | (4.3 | ) | 3.1 | ||||||||||
| Net cash provided by operating activities | 403.5 | 296.2 | 1,092.7 | 888.6 | ||||||||||||
| Cash flows from investing activities: | ||||||||||||||||
| Acquisitions and purchase of additional controlling interest, net of cash acquired of $4.6, $0.0, $4.9, and $1.8, respectively | (160.4 | ) | — | (184.8 | ) | (23.4 | ) | |||||||||
| Investments in non-public companies | (4.0 | ) | (0.9 | ) | (8.5 | ) | (0.4 | ) | ||||||||
| Proceeds received upon settlement of investment in non-public companies | — | — | — | 112.1 | ||||||||||||
| Capital expenditures | (67.4 | ) | (55.5 | ) | (176.9 | ) | (168.5 | ) | ||||||||
| Escrow (funding) release associated with acquisitions | (2.7 | ) | 3.8 | (2.7 | ) | 3.8 | ||||||||||
| Net cash used in investing activities | (234.5 | ) | (52.6 | ) | (372.9 | ) | (76.4 | ) | ||||||||
| Cash flows from financing activities: | ||||||||||||||||
| Proceeds from issuance of long-term debt, net of original discount | — | — | 698.3 | 590.2 | ||||||||||||
| Proceeds from the issuance of short-term debt | 1,497.9 | — | 1,497.9 | — | ||||||||||||
| Payment of debt issuance costs | (19.2 | ) | — | (25.4 | ) | (5.6 | ) | |||||||||
| Repayment of current portion of long-term debt | — | — | (500.0 | ) | — | |||||||||||
| Payment on early extinguishment of debt | — | — | — | (396.4 | ) | |||||||||||
| Repurchases of common stock | (100.1 | ) | (340.0 | ) | (400.2 | ) | (690.0 | ) | ||||||||
| Share repurchases not yet settled | — | (60.0 | ) | — | (60.0 | ) | ||||||||||
| Payment of contingent liability related to acquisition | — | — | — | (8.5 | ) | |||||||||||
| Payment of excise tax | — | — | (7.6 | ) | — | |||||||||||
| Proceeds from stock options exercised | 3.7 | 47.4 | 51.3 | 110.6 | ||||||||||||
| Net share settlement of taxes from restricted stock and performance share awards | (0.5 | ) | (0.4 | ) | (26.0 | ) | (13.0 | ) | ||||||||
| Dividends paid | (62.6 | ) | (55.3 | ) | (188.6 | ) | (166.6 | ) | ||||||||
| Other financing activities, net | (13.9 | ) | (13.0 | ) | (20.1 | ) | (18.9 | ) | ||||||||
| Net cash provided by (used in) financing activities | 1,305.3 | (421.3 | ) | 1,079.6 | (658.2 | ) | ||||||||||
| Effect of exchange rate changes | 4.9 | 3.6 | 17.3 | 1.3 | ||||||||||||
| Net increase (decrease) in cash and cash equivalents | 1,479.2 | (174.1 | ) | 1,816.7 | 155.3 | |||||||||||
| Cash and cash equivalents, beginning of period | 628.7 | 632.1 | 291.2 | 302.7 | ||||||||||||
| Cash and cash equivalents, end of period | $ | 2,107.9 | $ | 458.0 | $ | 2,107.9 | $ | 458.0 | ||||||||
| Supplemental disclosures: | ||||||||||||||||
| Income taxes paid | $ | 51.7 | $ | 77.0 | $ | 149.0 | $ | 218.4 | ||||||||
| Interest paid | $ | 24.9 | $ | 7.9 | $ | 84.8 | $ | 63.0 | ||||||||
| Noncash investing and financing activities: | ||||||||||||||||
| Deferred tax liability established on date of acquisition | $ | — | $ | — | $ | 2.5 | $ | 1.4 | ||||||||
| Finance lease additions | $ | 2.2 | $ | 5.9 | $ | 4.0 | $ | 28.4 | ||||||||
| Operating lease additions (terminations), net | $ | 2.2 | $ | (9.5 | ) | $ | 3.8 | $ | (5.7 | ) | ||||||
| Fixed assets included in accounts payable and accrued liabilities | $ | 0.1 | $ | — | $ | 0.2 | $ | — |
The accompanying notes are an integral part of these condensed consolidated financial statements.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(Amounts in millions, except for share and per share data, unless otherwise stated)
Verisk Analytics, Inc. (the "Company") is a strategic data analytics and technology partner to the global insurance industry. We empower clients to strengthen operating efficiency, improve underwriting and claims outcomes, combat fraud and make informed decisions about global risks, including climate change, extreme events, sustainability, and political issues. Through advanced data analytics, software, scientific research, and deep industry knowledge, we help build global resilience for individuals, communities, and businesses. We trade under the ticker symbol "VRSK" on the Nasdaq Global Select Market.
2. Basis of Presentation and Summary of Significant Accounting Policies:
Our accompanying unaudited condensed consolidated financial statements have been prepared on the basis of accounting principles generally accepted in the U.S. ("U.S. GAAP"). The preparation of financial statements in conformity with these accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates include acquisition purchase price allocations, the fair value of goodwill and intangibles, the realization of deferred tax assets and liabilities, acquisition-related liabilities, fair value of stock-based compensation for stock options and performance share units granted, and assets and liabilities for pension and postretirement benefits. Actual results may ultimately differ from those estimates.
Our condensed consolidated financial statements as of September 30, 2025 and for the three and nine months ended September 30, 2025 and 2024, in the opinion of management, include all adjustments, consisting of normal recurring items, to present fairly our financial position, results of operations, and cash flows. Our operating results for the three and nine months ended September 30, 2025 are not necessarily indicative of the results to be expected for the full year. Our condensed consolidated financial statements and related notes as of and for the three and nine months ended September 30, 2025 have been prepared on the same basis as and should be read in conjunction with our annual report on Form 10-K for the year ended December 31, 2024. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the rules of the SEC. We believe the disclosures made are adequate to keep the information presented from being misleading.
Recent Accounting Pronouncements
| Accounting Standard | Description | Effective Date | Effect on Consolidated Financial Statements or Other Significant Matters |
|---|---|---|---|
| Income Taxes (Topic 740) In December 2023, the FASB issued Accounting Standards Update ("ASU") No. 2023-09, Improvements to Income Tax Disclosures ("ASU No. 2023-09") | The amendments within ASU No. 2023-09 address investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This Update also includes certain other amendments to improve the effectiveness of income tax disclosures | The ASU’s amendments are effective for public business entities for fiscal years beginning after December 15, 2024. Early adoption is permitted. | We plan to adopt ASU 2023-09 within our December 31, 2025 financial statements. The adoption of this guidance is not expected to have a material impact on our condensed consolidated financial statements. |
| Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40) In November 2024, the FASB issued Accounting Standards Update ("ASU") No. 2024-03, Disaggregation of Income Statement Expenses ("ASU No. 2024-03") | The amendments in ASU 2024-03 require additional disclosure of the nature of expenses included in the income statement as well as disclosures about specific types of expenses included in the expense captions presented in the income statement. | The ASU is effective for the Company’s Annual Report on Form 10-K for the year ended December 31, 2027, and interim period reporting beginning in fiscal 2028 on a prospective basis. | We are currently evaluating the impact that the adoption of this standard will have on its condensed consolidated financial statements. |
| Intangibles - Goodwill and Other - Internal Use Software (Subtopic 350-40) In September 2025, the FASB issued Accounting Standards Update ("ASU") No. 2025-06, Targeted Improvements to the Accounting for Internal-Use Software ("ASU No. 2024-03") | ASU 2025-06 modernizes the accounting for internal-use software under ASC 350-40 by aligning it with current development practices, especially agile and iterative methods. It clarifies when to begin capitalizing costs, improves operability across different development approaches, and enhances disclosure requirements. | This update is effective for interim and annual periods beginning after December 15, 2027, with early adoption permitted. | We are currently evaluating the impact of the adoption of this standard on our consolidated financial statements. |
7
Disaggregated revenues by type of service and by country are provided below for the three and nine months ended September 30, 2025 and 2024. No individual customer or country outside of the U.S. accounted for 10% or more of our consolidated revenues for the three and nine months ended September 30, 2025 or 2024.
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Insurance: | ||||||||||||||||
| Underwriting | $ | 542.1 | $ | 506.9 | $ | 1,623.7 | $ | 1,512.8 | ||||||||
| Claims | 226.2 | 218.4 | 670.2 | 633.3 | ||||||||||||
| Total revenues | $ | 768.3 | $ | 725.3 | $ | 2,293.9 | $ | 2,146.1 |
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Revenues: | ||||||||||||||||
| United States | $ | 631.9 | $ | 604.1 | $ | 1,880.9 | $ | 1,778.8 | ||||||||
| United Kingdom | 63.7 | 53.3 | 186.8 | 156.2 | ||||||||||||
| Other countries | 72.7 | 67.9 | 226.2 | 211.1 | ||||||||||||
| Total revenues | $ | 768.3 | $ | 725.3 | $ | 2,293.9 | $ | 2,146.1 |
Contract assets are defined as an entity's right to consideration in exchange for goods or services that the entity has transferred to a customer when that right is conditioned on something other than the passage of time. As of September 30, 2025 and December 31, 2024, we had no contract assets. Contract liabilities are defined as an entity's obligation to transfer goods or services to a customer for which the entity has received consideration (or an amount of consideration is due) from the customer. As of September 30, 2025 and December 31, 2024, we had contract liabilities that primarily related to unsatisfied performance obligations to provide customers with the right to use and update the online content over the remaining contract term of $507.0 million and $451.1 million, respectively. Contract liabilities, which are current and noncurrent, are included in "Deferred revenues" and "Other noncurrent liabilities" in our condensed consolidated balance sheets, as of September 30, 2025 and December 31, 2024.
The following is a summary of the change in contract liabilities from December 31, 2024 through September 30, 2025:
| Contract liabilities at December 31, 2024 | $ | 451.1 | ||
|---|---|---|---|---|
| Additions to contract liabilities | 2,347.5 | |||
| Total revenues | (2,293.9 | ) | ||
| Foreign currency translation adjustment | 2.3 | |||
| Contract liabilities at September 30, 2025 | $ | 507.0 |
Our most significant remaining performance obligations relate to providing customers with the right to use and update the online content over the remaining contract term. Our disclosure of the timing for satisfying the performance obligation is based on the requirements of contracts with customers. However, from time to time, these contracts may be subject to modifications, impacting the timing of satisfying the performance obligations. These performance obligations, which are expected to be satisfied within one year, comprised approximately 99% and 98% of the balance at September 30, 2025 and December 31, 2024, respectively.
We recognize an asset for incremental costs of obtaining a contract with a customer if we expect the benefits of those costs to be longer than one year. As of September 30, 2025 and December 31, 2024, we had deferred commissions of $80.4 million and $78.5 million, respectively, which have been included in "Prepaid expenses" and "Other noncurrent assets" in our accompanying condensed consolidated balance sheets.
8
4. Investments and Fair Value Measurements:
We have certain assets and liabilities that are reported at fair value in our accompanying condensed consolidated balance sheets. To increase consistency and comparability of assets and liabilities recorded at fair value, ASC 820-10, Fair Value Measurements, established a three-level fair value hierarchy to prioritize the inputs to valuation techniques used to measure fair value. ASC 820-10 requires disclosures detailing the extent to which companies measure assets and liabilities at fair value, the methods and assumptions used to measure fair value, and the effect of fair value measurements on earnings. In accordance with ASC 820-10, we applied the following fair value hierarchy:
| Level 1 - | Assets or liabilities for which the identical item is traded on an active exchange, such as publicly-traded instruments. |
|---|---|
| Level 2 - | Assets or liabilities valued based on observable market data for similar instruments. |
| Level 3 - | Assets or liabilities for which significant valuation assumptions are not readily observable in the market; instruments valued based on the best available data, some of which are internally-developed, and considers risk premiums that market participants would require. |
The fair values of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, and short-term debt approximate their carrying amounts, because of the short-term nature of these instruments. Our investments in registered investment companies, which are Level 1 assets measured at fair value on a recurring basis, was $0.7 million and $1.2 million as of September 30, 2025 and December 31, 2024, respectively. Our investments in registered investment companies are valued using quoted prices in active markets multiplied by the number of shares owned and were included in "Other current assets" in our accompanying condensed consolidated balance sheets.
We elected not to carry our long-term debt at fair value. The carrying value of the long-term debt represents amortized cost, inclusive of unamortized premium, and net of unamortized discount and debt issuance costs. We assess the fair value of these financial instruments based on an estimate of interest rates available to us for financial instruments with similar features, our current credit rating, and spreads applicable to us. The following table summarizes the carrying value and estimated fair value of these financial instruments as of September 30, 2025 and December 31, 2024, respectively:
| September 30, 2025 | December 31, 2024 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fair Value | Carrying | Estimated | Carrying | Estimated | |||||||||||||
| Hierarchy | Value | Fair Value | Value | Fair Value | |||||||||||||
| Financial instruments not carried at fair value: | |||||||||||||||||
| Senior notes (Note 9) | Level 2 | $ | 4,700.7 | $ | 4,683.6 | $ | 3,021.0 | $ | 2,866.5 |
As of September 30, 2025 and December 31, 2024, we had securities without readily determinable market values of $201.3 million and $195.3 million, respectively, which were accounted for at cost. We do not have the ability to exercise significant influence over the investees’ operating and financial policies and do not hold investments in common stock or in-substance common stock in such entities. As of September 30, 2025 and December 31, 2024, we also had investments in private companies of $29.8 million and $27.0 million, respectively, accounted for in accordance with ASC 323-10-25, The Equity Method of Accounting for Investments in Common Stock ("ASC 323-10-25"), as equity method investments. All such investments were included in "Other noncurrent assets" in our accompanying condensed consolidated balance sheets. For the three and nine months ended September 30, 2025, there was no provision for credit losses related to these investments.
9
We have operating and finance leases for corporate offices, data centers, and certain equipment that are accounted for under ASC 842, Leases ("ASC 842").
The following table presents the consolidated lease cost and cash paid for amounts included in the measurement of lease liabilities for finance and operating leases for the three and nine months ended September 30, 2025 and 2024, respectively:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Lease cost: | ||||||||||||||||
| Operating lease cost (1) | $ | 7.6 | $ | 8.3 | $ | 22.7 | $ | 25.0 | ||||||||
| Sublease income | (1.4 | ) | (1.1 | ) | (3.1 | ) | (3.2 | ) | ||||||||
| Finance lease costs: | ||||||||||||||||
| Depreciation of finance lease assets (2) | 5.5 | 5.0 | 15.7 | 14.3 | ||||||||||||
| Interest on finance lease liabilities (3) | 0.4 | 0.5 | 1.5 | 1.7 | ||||||||||||
| Total lease cost | $ | 12.1 | $ | 12.7 | $ | 36.8 | $ | 37.8 | ||||||||
| Other information: | ||||||||||||||||
| Cash paid for amounts included in the measurement of lease liabilities | ||||||||||||||||
| Operating cash outflows from operating leases | $ | (9.4 | ) | $ | (9.0 | ) | $ | (25.3 | ) | $ | (25.6 | ) | ||||
| Operating cash outflows from finance leases | $ | (0.4 | ) | $ | (0.5 | ) | $ | (1.5 | ) | $ | (1.7 | ) | ||||
| Financing cash outflows from finance leases | $ | (13.9 | ) | $ | (13.0 | ) | $ | (20.1 | ) | $ | (18.9 | ) |
(1) Included in "Cost of revenues" and "Selling, general and administrative" expenses in our accompanying condensed consolidated statements of operations
(2) Included in "Depreciation and amortization of fixed assets" in our accompanying condensed consolidated statements of operations
(3) Included in "Interest expense" in our accompanying condensed consolidated statements of operations
The following table presents weighted-average remaining lease terms and weighted-average discount rates for the consolidated finance and operating leases as of September 30, 2025 and 2024, respectively:
| September 30, | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | |||||||
| Weighted-average remaining lease term - operating leases (in years) | 6.3 | 7.2 | ||||||
| Weighted-average remaining lease term - finance leases (in years) | 2.7 | 3.3 | ||||||
| Weighted-average discount rate - operating leases | 3.8 | % | 4.1 | % | ||||
| Weighted-average discount rate - finance leases | 4.1 | % | 4.2 | % |
Our right-of-use ("ROU") assets and lease liabilities for finance leases were $34.2 million and $25.1 million, respectively, as of September 30, 2025. Our ROU assets and lease liabilities for finance leases were $47.7 million and $41.4 million, respectively, as of December 31, 2024. Our ROU assets for finance leases were included in "Fixed assets, net" in our accompanying condensed consolidated balance sheets. Our lease liabilities for finance leases were included in the "Short-term debt and current portion of long-term debt" and "Long-term debt" in our accompanying condensed consolidated balance sheets (see Note 9. Debt).
Maturities of lease liabilities for the remainder of 2025 and the years through 2030 and thereafter are as follows:
| September 30, 2025 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Years Ending | Operating Leases | Finance Leases | ||||||
| 2025 | $ | 8.6 | $ | 4.2 | ||||
| 2026 | 32.4 | 11.2 | ||||||
| 2027 | 31.8 | 8.9 | ||||||
| 2028 | 30.5 | 4.6 | ||||||
| 2029 | 29.1 | 0.1 | ||||||
| 2030 and thereafter | 62.1 | — | ||||||
| Total lease payments | 194.5 | 29.0 | ||||||
| Less: amount representing interest | (23.8 | ) | (3.9 | ) | ||||
| Present value of total lease payments | $ | 170.7 | $ | 25.1 |
10
2025 Acquisitions
On July 17, 2025, we completed the acquisition of SuranceBay, LLC ("SuranceBay"), a leading provider of producer licensing, onboarding, appointment and compliance solutions for the life and annuity industry for $163.1 million in cash This acquisition underscores our commitment to streamlining and automating the process of buying and selling insurance, and to supporting a robust life and annuity ecosystem with solutions that enhance workflows among carriers, general agencies, insurance agencies and consumers.
On April 2, 2025, we completed the acquisition of 100 percent of the stock of Nasdaq subsidiary Simplitium Limited ("Simplitium"), for a cash purchase price of $19.7 million. The acquisition will provide Verisk clients with access to 300+ third-party models, providing unique, niche views of risk across the globe. The acquisition will further our expansion in Europe and our goal of helping insurers and claims service providers leverage more holistic data and technology tools to enhance the claims experience.
The preliminary purchase price allocation of the 2025 acquisitions resulted in the following:
| SuranceBay | Simplitium | Total | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | $ | 4.6 | $ | 0.3 | $ | 4.9 | ||||||
| Accounts receivable | 1.6 | 3.4 | 5.0 | |||||||||
| Prepaid assets | — | 0.6 | 0.6 | |||||||||
| Other current assets | 2.7 | — | 2.7 | |||||||||
| Intangible assets | 80.6 | 9.8 | 90.4 | |||||||||
| Goodwill | 81.2 | 11.9 | 93.1 | |||||||||
| Total assets acquired | 170.7 | 26.0 | 196.7 | |||||||||
| Accounts payable and accrued liabilities | 0.3 | 0.7 | 1.0 | |||||||||
| Deferred revenues | — | 2.7 | 2.7 | |||||||||
| Income tax payable | — | 0.1 | 0.1 | |||||||||
| Deferred income tax liability | — | 2.5 | 2.5 | |||||||||
| Other Liabilities | 2.7 | — | 2.7 | |||||||||
| Total liabilities assumed | 3.0 | 6.0 | 9.0 | |||||||||
| Net assets acquired | 167.7 | 20.0 | 187.7 | |||||||||
| Less: cash acquired | 4.6 | 0.3 | 4.9 | |||||||||
| Net cash purchase price | $ | 163.1 | $ | 19.7 | $ | 182.8 |
The preliminary amounts assigned to intangible assets by type for the 2025 acquisitions are summarized in the table below:
| Weighted Average Useful Life (in years) | Total | |||||||
|---|---|---|---|---|---|---|---|---|
| Technology-based | 8 | $ | 36.7 | |||||
| Marketing-related | 5 | 0.9 | ||||||
| Customer-related | 13 | 52.8 | ||||||
| Total intangible assets | $ | 90.4 |
The preliminary allocations of the purchase price for the 2025 acquisition with less than a year of ownership are subject to revisions as additional information is obtained about the facts and circumstances that existed as of each acquisition date. The revisions may have a significant impact on our condensed consolidated financial statements. The allocations of the purchase price will be finalized once all the information that was known as of the acquisition date is obtained and analyzed, but not to exceed one year from the acquisition date. The primary areas of the purchase price allocation that are not yet finalized relate to income and non-income taxes, deferred revenues, the valuation of intangible assets acquired, and residual goodwill. The goodwill associated with our acquisition includes the acquired assembled workforce, the value associated with the opportunity to leverage the work force to continue to develop the technology and content assets, as well as our ability to grow through adding additional customer relationships or new solutions in the future. Of the $93.1 million in goodwill associated with our acquisitions, $11.9 million is not deductible for tax purposes. The preliminary amounts assigned to intangible assets by type for these acquisitions were based upon our valuation model and historical experiences with entities with similar business characteristics.
For the three and nine months ended September 30, 2025 and 2__024, we incurred transaction costs of $3.9 million and $0.2 million, and $4.8 million and $0.3 million, respectively. The transaction costs were included within "Selling, general and administrative" expenses in our accompanying condensed consolidated statements of operations.
11
Supplemental information on an unaudited pro forma basis is presented below as if the acquisition of SuranceBay occurred at the beginning of fiscal year 2024. The pro forma information for the three and nine months ended September 30, 2025 and 2024 presented below is based on estimates and assumptions, which we believe to be reasonable but not necessarily indicative of the consolidated financial position or results of operations in future period or the results that actually would have been realized had this acquisition been completed at the beginning of fiscal year 2024. The unaudited pro forma information does not give effect to any anticipated cost savings, operating efficiencies, or other synergies that may be associated with the acquisition, or any estimated costs that have been or will be incurred by us to integrate the assets and operations of SuranceBay.
SuranceBay contributed revenues and net income of $4.1 million and $1.6 million for the three and nine months ended September 30, 2025.
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Pro forma revenues | $ | 769.0 | $ | 729.7 | $ | 2,304.7 | $ | 2,159.0 | ||||||||
| Pro forma net income | 225.9 | 220.7 | 713.7 | 749.5 | ||||||||||||
| Pro forma basic income per share | 1.62 | 1.56 | 5.10 | 5.26 | ||||||||||||
| Pro forma diluted income per share | 1.61 | 1.55 | 5.08 | 5.23 |
Acquisition Escrows and Related Liabilities
Pursuant to the related acquisition agreements, we have funded various escrow accounts to satisfy pre-acquisition indemnity and tax claims arising subsequent to the applicable acquisition dates. At September 30, 2025 and December 31, 2024, the current portion of the escrows amounted to $2.7 million and $0.0 million, respectively. There were no noncurrent portions of the escrows. The current portion of the escrows have been included in "Other current assets" in our accompanying condensed consolidated balance sheets.
As of September 30, 2025, the acquisition of SuranceBay and Morning Data Limited ("Morning Data") included an acquisition-related contingent payment, for which the sellers of these acquisitions could receive additional payments by achieving the specific predetermined revenue, EBITDA margin, and/or cash EBITDA earn-out targets for exceptional performance. We believe that the liabilities recorded as of September 30, 2025 and December 31, 2024 reflect the best estimate of acquisition-related contingent payments. There was no associated current portion of the contingent payments as of September 30, 2025 and December 31, 2024. The associated noncurrent portion of acquisition-related contingent payments was $0.6 million and $2.2 million as of September 30, 2025 and December 31, 2024, respectively.
12
7. Goodwill and Intangible Assets:
The following is a summary of the change in goodwill from December 31, 2024 through September 30, 2025:
| Insurance | ||||
|---|---|---|---|---|
| Goodwill at December 31, 2024 | $ | 1,726.6 | ||
| Purchase accounting reclassifications | 0.1 | |||
| Acquisitions | 93.1 | |||
| Foreign currency translation adjustment | 58.8 | |||
| Goodwill at September 30, 2025 | $ | 1,878.6 |
Goodwill and intangible assets with indefinite lives are subject to impairment testing annually as of June 30, or whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable. When evaluating goodwill for impairment, we may decide to first perform a qualitative assessment, or “Step Zero” impairment test, to determine whether it is more likely than not that impairment has occurred. The qualitative assessment includes a review of macroeconomic conditions, industry and market considerations, internal cost factors, and our own overall financial and share price performance, among other factors. If we do not perform a qualitative assessment, or if we determine that it is more likely than not that the carrying amounts of our reporting units exceeds their fair value, we perform a quantitative assessment and calculate the estimated fair value of the respective reporting unit. If the carrying amount of a reporting unit’s goodwill exceeds the fair value of that goodwill, an impairment loss is recognized. As of June 30, 2025, we completed our step zero impairment test at the reporting unit level and determined it was not more likely than not that the carrying values of our reporting units exceeded their fair values. We did not recognize any additional impairment charges related to our goodwill and indefinite-lived intangible assets. During the three months ended September 30, 2025, we continued to monitor these reporting units for events that would trigger an interim impairment test; we did not identify such events.
Impairments to long lived assets for the three and nine months ended September 30, 2025 and 2024 were $0.0 million and $7.6 million, respectively. During August 2024, we early vacated two floors at our Jersey City, New Jersey, corporate headquarters. As a result, we assessed the related long-lived assets at the site for impairment and recognized $7.6 million of impairment charges, primarily related to the write-off of the remaining balance of leasehold improvements.
Our intangible assets and related accumulated amortization consisted of the following:
| Weighted Average Useful Life (in years) | Cost | Accumulated Amortization | Net | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| September 30, 2025 | ||||||||||||||||
| Technology-based | 8 | $ | 411.3 | $ | (310.5 | ) | $ | 100.8 | ||||||||
| Marketing-related | 6 | 40.1 | (37.8 | ) | 2.3 | |||||||||||
| Contract-based | 6 | 5.0 | (5.0 | ) | — | |||||||||||
| Customer-related | 13 | 599.6 | (259.3 | ) | 340.3 | |||||||||||
| Database-based | 8 | 15.5 | (11.3 | ) | 4.2 | |||||||||||
| Total intangible assets | $ | 1,071.5 | $ | (623.9 | ) | $ | 447.6 | |||||||||
| December 31, 2024 | ||||||||||||||||
| Technology-based | 8 | $ | 364.9 | $ | (285.3 | ) | $ | 79.6 | ||||||||
| Marketing-related | 6 | 37.8 | (35.5 | ) | 2.3 | |||||||||||
| Contract-based | 6 | 5.0 | (5.0 | ) | — | |||||||||||
| Customer-related | 13 | 529.1 | (224.0 | ) | 305.1 | |||||||||||
| Database-based | 8 | 15.1 | (9.7 | ) | 5.4 | |||||||||||
| Total intangible assets | $ | 951.9 | $ | (559.5 | ) | $ | 392.4 |
Amortization expense related to intangible assets for the three months ended September 30, 2025 and 2024 was $18.3 million and $18.3 million, respectively. Amortization expense related to the intangible assets for nine months ended September 30, 2025 and 2024 was $50.4 million and $55.0 million, respectively. Estimated amortization expense for the remainder of 2025 and the years through 2030 and thereafter for intangible assets subject to amortization is as follows:
| Years Ending | Amount | |||
|---|---|---|---|---|
| 2025 | $ | 18.1 | ||
| 2026 | 71.1 | |||
| 2027 | 62.6 | |||
| 2028 | 55.4 | |||
| 2029 | 50.4 | |||
| 2030 and thereafter | 190.0 | |||
| Total | $ | 447.6 |
13
Our effective tax rate for the three and nine months ended September 30, 2025 was 25.3% and 23.2% compared to the effective tax rate for the three and nine months ended September 30, 2024 of 22.9% and 21.6%, respectively. The increase in the effective tax rate was primarily due to a nonrecurring tax benefit recognized in the prior period, as well as lower tax benefits from equity compensation in the current period versus the prior period. The difference between statutory tax rates and our effective tax rate is primarily due to state and local taxes, partially offset by tax benefits attributable to equity compensation.
The One Big Beautiful Bill Act ("OBBBA") was signed into law on July 4, 2025. The OBBBA contains several changes to U.S. federal tax law, including expensing of U.S. research and experimental costs and makes permanent several provisions from the 2017 Tax Cuts and Jobs Act. The changes introduced in the OBBBA are not expected to have a material impact on our results of operations.
14
The following table presents short-term and long-term debt by issuance as of September 30, 2025 and December 31, 2024:
| Issuance Date | Maturity Date | 2025 | 2024 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Short-term debt and current portion of long-term debt: | ||||||||||
| Term Loan Facility | $ | — | $ | — | ||||||
| Credit Facilities: | ||||||||||
| Syndicated revolving credit facility | Various | Various | — | — | ||||||
| Senior notes: | ||||||||||
| 4.500% senior notes, less unamortized discount and debt issuance costs of $(6.2) | 8/8/2025 | 8/15/2030(2) | 743.8 | — | ||||||
| 5.125% senior notes, less unamortized discount and debt issuance costs of $(8.1) | 8/8/2025 | 2/15/2036(2) | 741.9 | — | ||||||
| 4.000% senior notes, less unamortized discount and debt issuance costs of $0.0 and $(0.3), respectively | 5/15/2015 | 6/15/2025 | — | 499.7 | ||||||
| Finance lease liabilities (1) | Various | Various | 9.0 | 14.5 | ||||||
| Term loan facility debt issuance costs | (5.8 | ) | — | |||||||
| Short-term debt and current portion of long-term debt | 1,488.9 | 514.2 | ||||||||
| Long-term debt: | ||||||||||
| Senior notes: | ||||||||||
| 3.625% senior notes, less unamortized discount and debt issuance costs of $(8.9) and $(9.2), respectively | 5/13/2020 | 5/15/2050 | 491.1 | 490.8 | ||||||
| 4.125% senior notes, inclusive of unamortized premium, and net of unamortized discount and debt issuance costs, of $5.2 and $6.3, respectively | 3/6/2019 | 3/15/2029 | 605.2 | 606.3 | ||||||
| 5.250% senior notes, less unamortized discount and debt issuance costs of $(13.1) and $(14.2), respectively | 6/5/2024 | 6/5/2034 | 586.9 | 585.8 | ||||||
| 5.250% senior notes, less unamortized discount and debt issuance costs of $(7.5) | 3/11/2025 | 3/15/2035 | 692.5 | — | ||||||
| 5.500% senior notes, less unamortized discount and debt issuance costs of $(3.5) and $(3.7), respectively | 5/15/2015 | 6/15/2045 | 346.5 | 346.3 | ||||||
| 5.750% senior notes, less unamortized discount and debt issuance costs of $(7.2) and $(7.9), respectively | 3/3/2023 | 4/1/2033 | 492.8 | 492.1 | ||||||
| Finance lease liabilities (1) | Various | Various | 16.1 | 26.9 | ||||||
| Syndicated revolving credit facility debt issuance costs | Various | Various | (1.9 | ) | (1.3 | ) | ||||
| Long-term debt | 3,229.2 | 2,546.9 | ||||||||
| Total debt | $ | 4,718.1 | $ | 3,061.1 |
(1) Refer to Note 5. Leases
(2) Refer to below for details on the classification of the 2030 Senior and 2036 Senior Notes.
Senior Notes
As of September 30, 2025 and December 31, 2024, we had senior notes with an aggregate principal amount of $4,750.0 million and $3,050.0 million outstanding, respectively, and were in compliance with our financial and other covenants.
On March 11, 2025, we completed an issuance of $700.0 million aggregate principal amount of 5.250% senior notes due 2035 (the "2035 Senior Notes"). The 2035 Senior Notes will mature on March 15, 2035 and accrue interest at a fixed rate of 5.250% per annum. Interest is payable semiannually on March 15 and September 15 of each year, beginning September 15, 2025. The 2035 Senior Notes were issued at a discount of $1.7 million and we incurred debt issuance costs of $6.2 million. The original issuance discount and debt issuance costs were recorded in "Long-term debt" in the accompanying condensed consolidated balance sheets and these costs will be amortized to "Interest expense" in the accompanying consolidated statements of operations over the life of the 2035 Senior Notes. In April 2025, we used a portion of the net proceeds of this offering to repay our 4.000% Senior Notes due 2025 (the “2025 Senior Notes”), which had an aggregate principal amount of $500.0 million. We intend to use the remaining net proceeds for general corporate purposes. The indenture governing the 2035 Senior Notes restricts our ability to, among other things, create certain liens, enter into sale/leaseback transactions and consolidate with, sell, lease, convey or otherwise transfer all or substantially all of our assets, or merge with or into, any other person or entity.
On August 21, 2025, we completed an issuance of $750.0 million aggregate principal amount of 4.500% senior notes due 2030 (the "2030 Senior Notes") and $750.0 million aggregate principal amount of 5.125% senior notes due 2036 (the "2036 Senior Notes"). The 2030 Senior Notes will bear interest at a fixed rate of 4.500% per annum and mature on August 15, 2030. The 2036 Senior Notes will bear interest at a fixed rate of 5.125% per annum and mature on February 15, 2036. We will pay interest on each series of notes on February 15 and August 15 of each year, beginning on February 15, 2026. The 2030 Senior Notes were issued at a discount of $0.4 million and we incurred debt issuance costs of $6.0 million. The 2036 Senior Notes were issued at a discount of $1.7 million and we incurred debt issuance costs of $6.4 million. The original issuance discount and debt issuance costs were recorded in "Short-term debt and current portion of long-term debt" in the accompanying condensed consolidated balance sheets and these costs will be amortized to "Interest expense" in the accompanying consolidated statements of operations over the life of the 2030 and 2036 Senior Notes. We intend to use the net proceeds of these offerings to finance the purchase price for the acquisition of AccuLynx and to pay related fees and expenses.
On July 29, 2025, we entered into a definitive agreement to acquire ExactLogix, Inc. ("AccuLynx") for $2.35 billion in cash. In the event the acquisition of AccuLynx is not completed by January 5, 2026, or by a later date mutually agreed upon by us and AccuLynx (referred to as the "special mandatory redemption end date"), we will notify the trustee of the senior notes that we will no longer pursue the acquisition. As a result, we will be required to redeem the entire aggregate principal amount of the 2030 Senior Notes and the 2036 Senior Notes. The redemption price would be equal to 101 percent of the total principal amount of the notes, plus any accrued and unpaid interest up to, but not including the special mandatory redemption end date. Due to the special mandatory redemption clause within the agreement, the 2030 and 2036 Senior notes are classified as current portion of long-term debt within "Short-term debt and current portion of long-term debt" in the accompanying condensed consolidated balance sheets.
15
Credit Facilities
We had a syndicated revolving credit facility ("Syndicated Revolving Credit Facility") with a borrowing capacity of $1,000.0 million with Bank of America N.A., HSBC Bank USA, N.A., JP Morgan Chase Bank, N.A., Wells Fargo Bank, National Association, Citibank, N.A., Morgan Stanley Bank, N.A., TD Bank, N.A., Goldman Sachs Bank USA, and the Northern Trust Company with a maturity date of April 5, 2028. On August 15, 2025, we entered into the Third Amended and Restated Credit Agreement (the "Amendment and Restatement") to the Syndicated Revolving Credit Facility with Bank of America, N.A. as administrative agent. The Amendment and Restatement increased our borrowing capacity to $1,250.0 million and extends the maturity date in respect to the Syndicated Revolving Credit Facility to August 15, 2030. Interest on borrowings under the Amendment and Restatement is payable at an interest rate of SOFR plus 100.0 to 162.5 basis points, depending upon our public debt rating. A commitment fee on any unused commitment is payable periodically and may range from 8.0 to 17.5 basis points based upon our public debt rating. The Syndicated Revolving Credit Facility, as amended and restated by the Amendment and Restatement, also contains certain financial and other covenants that, among other things, impose certain restrictions on indebtedness, liens, dispositions fundamental changes, and use of proceeds. The financial covenants require that, at the end of any fiscal quarter, we have a consolidated interest coverage ratio of more than 3.00 to 1.00, we have a consolidated funded debt leverage ratio of less than 3.75 to 1.00. At our election, the maximum consolidated funded debt leverage ratio could be permitted to increase to 4.50 to 1.00 (no more than once) and to 4.25 to 1.00 (no more than once) in connection with the closing of a permitted acquisition. The Syndicated Revolving Credit Facility may be used for general corporate purposes, including working capital needs and capital expenditures, acquisitions, dividend payments, and the share repurchase program (the "Repurchase Program"). In connection with the Amendment and Restatement, we incurred additional debt issuance costs of $1.0 million, which will be amortized to 'Interest expense' within the accompanying consolidated statements of operations over the remaining life of the Syndicated Revolving Credit Facility. As of September 30, 2025, we were in compliance with all financial and other debt covenants under our Syndicated Revolving Credit Facility. As of September 30, 2025 and December 31, 2024, the available capacity under the Syndicated Revolving Credit Facility was $1,245.5 million and $995.4 million, which takes into account outstanding letters of credit of $4.5 million and $4.6 million, respectively.
On August 15, 2025, we also entered into a $750.0 million Term Credit Agreement (the "Term Loan Facility") with Bank of America N.A. The Term Loan Facility has a maturity date of August 15, 2028 and carries an interest rate of SOFR plus 100.0 to 162.5 basis points, depending upon our public debt rating. The Term Loan Facility also contains certain financial and other covenants that, among other things, impose certain restrictions on indebtedness, liens, dispositions fundamental changes, and use of proceeds. The financial covenants require that, at the end of any fiscal quarter, we have a consolidated interest rate coverage ratio of less than 3.00 to 1.00, and a consolidated funded debt leverage ratio of greater than 3.75 to 1.00. At our election, the maximum consolidated funded debt leverage ratio could be permitted to increase to 4.50 to 1.00 (no more than once) and to 4.25 to 1.00 (no more than once) in connection with the closing of a permitted acquisition. We plan to use the borrowings to finance the purchase price for the acquisition of AccuLynx and to pay related fees and expenses. In connection with the Term Loan Facility, we incurred additional debt issuance costs of $5.8 million, which will be amortized to "Interest expense" within the accompanying condensed consolidated statements of operations over the remaining life of the Term Loan Facility.
16
We have 2,000,000,000 shares of authorized common stock as of September 30, 2025 and December 31, 2024. Our common shares have rights to any dividend declared by the board of directors (the "Board"), subject to any preferential or other rights of any outstanding preferred stock, and voting rights to elect all current members of the Board. At September 30, 2025 and December 31, 2024, the adjusted closing price of our common stock was $251.51 and $275.43 per share, respectively.
We have 80,000,000 shares of authorized preferred stock, par value $0.001 per share. The preferred shares have preferential rights over the common shares with respect to dividends and net distribution upon liquidation. We did not issue any preferred shares as of September 30, 2025 and December 31, 2024.
On February 19, 2025, April 30, 2025, and July 23, 2025 our Board approved a cash dividend of $0.45 per share of common stock issued and outstanding to the holders of record as of March 14, 2025, June 13, 2025, and September 30, 2025, respectively. Cash dividends of $188.6 million and $166.6 million were paid during the nine months ended September 30, 2025 and 2024, respectively, and recorded as a reduction to retained earnings.
Share Repurchases
In November 2024, March 2025_,_ and May 2025, we entered into Accelerated Share Repurchase ("ASR") agreements (the "November 2024 ASR Agreement", "March 2025 ASR Agreement", and "May 2025 ASR Agreement", respectively) to repurchase shares of our common stock for an aggregate purchase price of $300.0 million, $200.0 million, and $100.0 million, with Citibank, N.A. for the November 2024 ASR Agreement and March 2025 ASR Agreement and Goldman Sachs & Co. LLC for the May 2025 ASR Agreement. Each ASR agreement is accounted for as a treasury stock transaction and forward stock purchase agreement indexed to our common stock. Upon the payment of the aggregate purchase prices on November 13, 2024, March 11, 2025, and May 20, 2025, we received initial deliveries of 885,663, 570,470, and 270,399 shares of our common stock, respectively. Upon the final settlements of the November 2024 ASR Agreement, March 2025 ASR Agreement, and May 2025 ASR Agreement in January 2025, April 2025, and June 2025, we received 189,909, 123,766, and 52,614 additional shares, respectively, as determined based on the volume weighted average share prices of our common stock, less a discount, of $278.92, $288.09, and $309.58 per share during the term of the November 2024 ASR Agreement, March 2025 ASR Agreement, and May 2025 ASR Agreement, respectively. The forward stock purchase agreements are classified as equity instruments under ASC 815-40, Contracts in Entity's Own Equity ("ASC 815-40_"_) and deemed to have a fair value of zero at the respective effective date. The aggregate purchase price was recorded as a reduction to stockholders' equity in our condensed consolidated statements of changes in stockholders' equity for the nine months ended September 30, 2025.
In August 2025, we entered into an additional ASR agreement (the "August 2025 ASR Agreement") to repurchase shares of our common stock for an aggregate purchase price of $50.0 million with HSBC Bank USA, National Association. Upon the payment of the aggregate purchase price on August 13, 2025, we received an initial delivery of 163,462 shares of our common stock. Upon the final settlement of the August 2025 ASR Agreement in September 2025, we received 26,179 additional shares, as determined based on the volume weighted average share price of our common stock, less a discount, of $263.66 per share during the term of the August 2025 ASR Agreement.
In July 2025, we repurchased $50.0 million of our common stock through open market repurchases. Through these open market repurchases, we received 180,462 shares at an average price of $277.07.
We utilized cash received from operations for these repurchases. As of September 30, 2025, we had $1,191.5 million (including an additional share repurchase authorization of $1,000.0 million) available on our authorization to repurchase shares. These repurchases for the nine months ended September 30, 2025 resulted in a reduction of outstanding shares used to calculate the weighted average common shares outstanding for basic and diluted earnings per share ("EPS").
During the nine months ended September 30, 2025 and 2024, we recorded total excise tax of $2.9 million and $30.0 million, respectively, which has been included within treasury stock, as part of the cost basis of the stock repurchased, and accounts payable and accrued liabilities in our condensed consolidated balance sheet as of September 30, 2025 and 2024.
Treasury Stock
As of September 30, 2025, our treasury stock consisted of 404,632,636 shares of common stock, carried at cost. During the nine months ended September 30, 2025, we transferred 533,027 shares of common stock from the treasury shares at a weighted average treasury stock price of $25.30 per share.
17
Earnings Per Share
Basic EPS is computed by dividing net income attributable to Verisk by the weighted average number of common shares outstanding during the period. The computation of diluted EPS is similar to the computation of basic EPS except that the denominator is increased to include the number of additional common shares that would have been outstanding, using the treasury stock method, if the dilutive potential common shares, including vested and nonvested stock options, nonvested restricted stock awards, nonvested restricted stock units, nonvested performance share units ("PSU"), and nonvested deferred stock units, had been issued.
The following is a presentation of the numerators and denominators of the basic and diluted EPS computations for the three and nine months ended September 30, 2025 and 2024:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Numerator used in basic and diluted EPS: | ||||||||||||||||
| Net income | $ | 225.5 | $ | 220.0 | $ | 711.1 | $ | 747.2 | ||||||||
| Less: Net loss attributable to noncontrolling interests | — | 0.1 | — | 0.6 | ||||||||||||
| Net income attributable to Verisk | $ | 225.5 | $ | 220.1 | $ | 711.1 | $ | 747.8 | ||||||||
| Denominator: | ||||||||||||||||
| Weighted average number of common shares used in basic EPS | 139,509,985 | 141,778,551 | 139,874,142 | 142,594,074 | ||||||||||||
| Effect of dilutive shares: | ||||||||||||||||
| Potential common shares issuable from stock options and stock awards | 431,950 | 732,925 | 532,868 | 665,337 | ||||||||||||
| Weighted average number of common shares and dilutive potential common shares used in diluted EPS | 139,941,935 | 142,511,476 | 140,407,010 | 143,259,411 |
The potential shares of common stock that were excluded from diluted EPS were 21,748 and 202,684 for the three months ended September 30, 2025 and 2024, and 24,018 and 237,062 for the nine months ended September 30, 2025 and 2024, respectively, because the effect of including those potential shares was anti-dilutive.
Accumulated Other Comprehensive Income
The following is a summary of accumulated other comprehensive income as of September 30, 2025 and December 31, 2024:
| 2025 | 2024 | |||||||
|---|---|---|---|---|---|---|---|---|
| Foreign currency translation adjustment | $ | 174.2 | $ | 90.1 | ||||
| Pension and postretirement adjustment, net of tax | (72.3 | ) | (75.1 | ) | ||||
| Accumulated other comprehensive income | $ | 101.9 | $ | 15.0 |
18
The before-tax and after-tax amounts of other comprehensive income (loss) income for the three and nine months ended September 30, 2025 and 2024 are summarized below:
| Before Tax | Tax (Expense) Benefit | After Tax | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| For the Three Months Ended September 30, 2025 | ||||||||||||
| Foreign currency translation adjustment attributable to Verisk | $ | (14.8 | ) | $ | — | $ | (14.8 | ) | ||||
| Foreign currency translation adjustment attributable to noncontrolling interests | (0.1 | ) | — | (0.1 | ) | |||||||
| Foreign currency translation adjustment | (14.9 | ) | — | (14.9 | ) | |||||||
| Pension and postretirement adjustment before reclassifications | 2.4 | $ | (0.5 | ) | 1.9 | |||||||
| Amortization of net actuarial loss and prior service benefit reclassified from accumulated other comprehensive income (1) | (1.2 | ) | 0.3 | (0.9 | ) | |||||||
| Pension and postretirement adjustment | 1.2 | (0.2 | ) | 1.0 | ||||||||
| Total other comprehensive income | $ | (13.7 | ) | $ | (0.2 | ) | $ | (13.9 | ) | |||
| For the Three Months Ended September 30, 2024 | ||||||||||||
| Foreign currency translation adjustment attributable to Verisk | $ | 46.9 | $ | — | $ | 46.9 | ||||||
| Foreign currency translation adjustment attributable to noncontrolling interests | 0.2 | — | 0.2 | |||||||||
| Foreign currency translation adjustment | 47.1 | — | 47.1 | |||||||||
| Pension and postretirement adjustment before reclassifications | 1.9 | (0.5 | ) | 1.4 | ||||||||
| Amortization of net actuarial loss and prior service benefit reclassified from accumulated other comprehensive income (1) | (0.9 | ) | 0.3 | (0.6 | ) | |||||||
| Pension and postretirement adjustment | 1.0 | (0.2 | ) | 0.8 | ||||||||
| Total other comprehensive loss | $ | 48.1 | $ | (0.2 | ) | $ | 47.9 |
| Before Tax | Tax (Expense) Benefit | After Tax | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| For the Nine Months Ended September 30, 2025 | ||||||||||||
| Foreign currency translation adjustment attributable to Verisk | $ | 84.1 | $ | — | $ | 84.1 | ||||||
| Foreign currency translation adjustment attributable to noncontrolling interests | 0.3 | — | 0.3 | |||||||||
| Foreign currency translation adjustment | 84.4 | — | 84.4 | |||||||||
| Pension and postretirement adjustment before reclassifications | 6.9 | (1.6 | ) | 5.3 | ||||||||
| Amortization of net actuarial loss and prior service benefit reclassified from accumulated other comprehensive income (1) | (3.4 | ) | 0.9 | (2.5 | ) | |||||||
| Pension and postretirement adjustment | 3.5 | (0.7 | ) | 2.8 | ||||||||
| Total other comprehensive income | $ | 87.9 | $ | (0.7 | ) | $ | 87.2 | |||||
| For the Nine Months Ended September 30, 2024 | ||||||||||||
| Foreign currency translation adjustment attributable to Verisk | $ | 30.3 | $ | — | $ | 30.3 | ||||||
| Foreign currency translation adjustment attributable to noncontrolling interests | 1.1 | — | 1.1 | |||||||||
| Foreign currency translation adjustment | 31.4 | — | 31.4 | |||||||||
| Pension and postretirement adjustment before reclassifications | 6.3 | (1.5 | ) | 4.8 | ||||||||
| Amortization of net actuarial loss and prior service benefit reclassified from accumulated other comprehensive income (1) | (3.1 | ) | 0.8 | (2.3 | ) | |||||||
| Pension and postretirement adjustment | 3.2 | (0.7 | ) | 2.5 | ||||||||
| Total other comprehensive loss | $ | 34.6 | $ | (0.7 | ) | $ | 33.9 |
| (1) | These accumulated other comprehensive loss components, before tax, are included under "Cost of revenues" and "Selling, general and administrative" in our accompanying condensed consolidated statements of operations. These components are also included in the computation of net periodic (benefit) cost (see Note 12. Pension and Postretirement Benefits for additional details). |
|---|
19
11. Equity Compensation Plans:
All of our outstanding stock options, restricted stock awards, deferred stock units, and PSUs are covered under our 2021 Incentive Plan or our 2013 Incentive Plan. Awards under our 2021 Incentive Plan may include one or more of the following types: (i) stock options (both nonqualified and incentive stock options), (ii) stock appreciation rights, (iii) restricted stock, (iv) restricted stock units, (v) performance awards, (vi) other share-based awards, and (vii) cash. Employees, non-employee directors, and consultants are eligible for awards under our 2021 Incentive Plan. We transferred common stock under these plans from our treasury shares. As of September 30, 2025, there were 12,179,573 shares of common stock reserved and available for future issuance under our 2021 Incentive Plan. Cash received from stock option exercises for the nine months ended September 30, 2025 and 2024 was $51.3 million and $110.6 million, respectively.
We grant equity awards to our key employees. The nonqualified stock options have an exercise price equal to the adjusted closing price of our common stock on the grant date, with a ten-year contractual term. The fair value of the restricted stock is determined using the closing price of our common stock on the grant date. The restricted stock is not assignable or transferable until it becomes vested. PSUs vest at the end of a three-year performance period, subject to the recipient’s continued service. Each PSU represents the right to receive one share of our common stock and the ultimate realization is based on our achievement of certain market and financial performance criteria and may range from 0% to 200% of the recipient’s target levels of 100% established on the grant date. The fair value of PSUs based on market conditions is determined on the grant date using the Monte Carlo Simulation model. The fair value of PSUs based on financial performance conditions is determined using the closing price of our common stock on the grant date. We recognize the expense of the equity awards ratably over the vesting period, which could be up to four years.
In January 2025, we granted 212,590 nonqualified stock options, 125,835 shares of restricted stock, and 46,225 PSUs to key employees. The nonqualified stock options and restricted stock have a graded service vesting period of four years. The PSUs granted consisted of 28,822 PSUs that are based on the achievement of relative total shareholder return as compared to the companies that comprise the S&P 500 index ("TSR-based PSUs") and 17,403 PSUs that are tied to the achievement of certain financial performance conditions, namely incremental return on invested capital (“ROIC-based PSUs”). Each of the TSR-based PSUs and ROIC-based PSUs have a three-year performance period, subject to the recipients' continued service. The grant date fair value of the ROIC-based PSUs is determined using the closing price of our common stock on the grant date. The related performance condition is driven by the incremental return on invested capital based on net operating profit. The ultimate realization of the PSUs may range from 0% to 200% of the recipient’s target levels established on the grant date.
A summary of the status of the stock options, restricted stock, and PSUs awarded under our 2021 and 2013 Incentive Plans as of December 31, 2024 and September 30, 2025 and changes during the interim period are presented below:
| Stock Option | Restricted Stock | PSU | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Shares | Weighted Average Exercise Price | Aggregate Intrinsic Value | Number of Shares | Weighted Average Grant Date Fair Value Per Share | Number of Shares | Weighted Average Grant Date Fair Value Per Share | |||||||||||||||||||||||
| Outstanding at December 31, 2024 | 1,910,333 | $ | 161.16 | $ | 218.3 | 307,541 | $ | 210.62 | 180,456 | $ | 205.10 | ||||||||||||||||||
| Granted | 217,246 | $ | 273.60 | 157,329 | $ | 278.99 | 46,225 | $ | 309.25 | ||||||||||||||||||||
| Dividend reinvestment | — | $ | — | — | $ | — | 720 | ||||||||||||||||||||||
| Exercised or lapsed | (380,952 | ) | $ | 135.09 | $ | 61.7 | (114,518 | ) | $ | 208.83 | (84,592 | ) | $ | 167.90 | |||||||||||||||
| Canceled, expired or forfeited | (29,207 | ) | $ | 231.85 | (16,801 | ) | $ | 234.63 | (7,173 | ) | $ | 258.08 | |||||||||||||||||
| Outstanding at September 30, 2025 | 1,717,420 | $ | 179.96 | $ | 122.9 | 333,551 | $ | 242.64 | 135,635 | $ | 262.39 | ||||||||||||||||||
| Exercisable at September 30, 2025 | 1,199,545 | $ | 155.89 | $ | 114.7 | ||||||||||||||||||||||||
| Exercisable at December 31, 2024 | 1,345,181 | $ | 142.14 | $ | 179.3 | ||||||||||||||||||||||||
| Nonvested at September 30, 2025 | 517,875 | 333,551 | 135,635 | ||||||||||||||||||||||||||
| Expected to vest at September 30, 2025 | 430,179 | 293,798 | 153,713 | (1) |
| (1) | Includes estimated performance achievement |
|---|
20
The fair value of the stock options granted was estimated using a Black-Scholes valuation model that uses the weighted average assumptions noted in the following table for the nine months ended September 30, 2025 and 2024:
| 2025 | 2024 | |||||||
|---|---|---|---|---|---|---|---|---|
| Option pricing model | Black-Scholes | Black-Scholes | ||||||
| Weighted average grant price | $ | 273.60 | $ | 237.10 | ||||
| Expected volatility | 21.99 | % | 23.51 | % | ||||
| Risk-free interest rate | 4.35 | % | 3.89 | % | ||||
| Expected term in years | 3.5 | 3.7 | ||||||
| Dividend yield | 0.62 | % | 0.66 | % | ||||
| Weighted average grant date fair value per stock option | $ | 59.21 | $ | 53.45 |
The expected term for the stock options granted was estimated based on studies of historical experience and projected exercise behavior. However, for certain awards granted, for which no historical exercise pattern exists, the expected term was estimated using the simplified method. The risk-free interest rate is based on the yield of U.S. Treasury zero coupon securities with a maturity equal to the expected term of the equity award. The volatility factor is calculated using historical daily closing prices over the most recent period commensurate with the expected term of the stock option awards. The expected dividend yield was based on our expected annual dividend rate on the date of grant.
Intrinsic value for stock options is calculated based on the exercise price of the underlying awards and the adjusted closing price of our common stock as of the reporting date. Excess tax benefits from stock-based compensation were recorded as income tax benefit in our condensed consolidated statements of operations. This tax benefit is calculated as the excess of the intrinsic value of options exercised and restricted stock lapsed in excess of compensation recognized for financial reporting purposes. The weighted average remaining contractual terms were 5.6 years and 4.5 years for the outstanding and exercisable stock options, respectively, as of September 30, 2025.
As of September 30, 2025, there was $98.5 million of total unrecognized compensation costs, exclusive of the impact of vesting upon retirement eligibility, related to nonvested stock-based compensation arrangements granted under our 2021 and 2013 Incentive Plans. That cost is expected to be recognized over a weighted average period of 2.5 years.
Our U.K. Sharesave Plan offers qualifying employees in the United Kingdom the opportunity to own shares of our common stock. Employees who elect to participate are granted stock options, of which the exercise price is equal to the average of the closing price on the five trading days immediately preceding the plan invitation date discounted by 5%, and enter into a savings contract, the proceeds of which are then used to exercise the options upon the three-year maturity of the savings contract. During the nine months ended September 30, 2025, we granted 3,640 stock options under the U.K. Sharesave Plan at a discounted exercise price of $254.10. We did not grant any stock options under this plan for the nine months ended September 30, 2024. As of September 30, 2025, there were 435,859 shares of common stock reserved and available for future issuance under our U.K. Sharesave Plan.
Our ESPP offers eligible employees the opportunity to purchase shares of our common stock at a discount of its fair market value at the time of purchase. During the nine months ended September 30, 2025 and 2024, we issued 13,417 and 13,139 shares of common stock at a weighted discounted price of $271.1 and $243.31 for the ESPP, respectively. As of September 30, 2025, there were 1,146,878 shares of common stock reserved and available for future issuance under our ESPP.
21
12. Pension and Postretirement Benefits:
We maintain a frozen qualified defined benefit pension plan for certain employees through membership in our Pension Plan for Insurance Organizations (the "Pension Plan"), a multiple-employer trust. We also apply a cash balance formula to determine future benefits. Under the cash balance formula, each participant has an account, which is credited annually based on the interest earned on the previous year-end cash balance. We also have a frozen non-qualified supplemental cash balance plan ("SERP") for certain employees. The SERP is funded from our general assets. During the first quarter of 2025 and as of December 31, 2024, the investment guidelines on our Pension Plan assets targeted an investment allocation of 40% to equity securities and 60% to debt securities. We also provide certain healthcare and life insurance benefits to certain qualifying active and retired employees. Our Postretirement Health and Life Insurance Plan (the "Postretirement Plan"), which has been frozen, is contributory, requiring participants to pay a stated percentage of the premium for coverage.
The components of net periodic (benefit) cost for the three and nine months ended September 30, 2025 and 2024 are summarized below:
| Pension Plan and SERP | Postretirement Plan | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| For the Three Months Ended September 30, | ||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Interest cost | $ | 3.7 | $ | 3.8 | $ | 0.1 | $ | — | ||||||||
| Expected return on plan assets | (6.2 | ) | (6.2 | ) | (0.1 | ) | — | |||||||||
| Amortization of prior service cost | 0.1 | — | — | — | ||||||||||||
| Amortization of net actuarial loss | 0.9 | 0.8 | 0.2 | 0.1 | ||||||||||||
| Net periodic (benefit) cost | $ | (1.5 | ) | $ | (1.6 | ) | $ | 0.2 | $ | 0.1 | ||||||
| Employer contributions, net | — | $ | 0.1 | 0.8 | $ | 0.2 |
| Pension Plan and SERP | Postretirement Plan | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| For the Nine Months Ended September 30, | ||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Interest cost | $ | 11.2 | $ | 11.4 | $ | 0.2 | $ | 0.1 | ||||||||
| Expected return on plan assets | (18.7 | ) | (18.8 | ) | (0.2 | ) | (0.1 | ) | ||||||||
| Amortization of prior service cost | 0.2 | 0.2 | — | — | ||||||||||||
| Amortization of net actuarial loss | 2.8 | 2.5 | 0.4 | 0.4 | ||||||||||||
| Net periodic (benefit) cost | $ | (4.5 | ) | $ | (4.7 | ) | $ | 0.4 | $ | 0.4 | ||||||
| Employer contributions/(reimbursement), net | $ | 0.2 | $ | 0.5 | $ | (1.9 | ) | $ | 0.7 |
The expected contributions to the Pension Plan, SERP, and Postretirement Plan for the year ending December 31, 2025 are consistent with the amounts previously disclosed as of December 31, 2024.
22
ASC 280-10, Disclosures About Segments of an Enterprise and Related Information (“ASC 280-10”), establishes standards for reporting information about operating segments. ASC 280-10 requires that a public business enterprise reports financial and descriptive information about its reportable operating segments. Operating segments are components of an enterprise for which separate financial information is available that is evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing performance. Our President and CEO is identified as the CODM as defined by ASC 280-10.
Based on our business strategy along with the verticals we currently service, we have determined that we have one operating segment and one reportable segment, Insurance. The CODM uses EBITDA and consolidated net income to set budgets, evaluate margins, review actual results and in deciding whether to reinvest profits into the business, pursue acquisitions, pay dividends and/or engage in other capital management transactions. Consolidated net income is the measure of segment profit most consistent with U.S. GAAP that is regularly reviewed by the CODM to allocate resources and assess performance. For the quarter ended September 30, 2025 and year ended December 31, 2024 results, please refer to the Consolidated Statements of Operations for information regarding revenues, expenses, and the measure of profit and loss, which is net income. The CODM regularly reviews the Consolidated Statement of Operations. See Note 3. Revenues for information on disaggregated revenues by type of service and by country.
Long-lived assets by country are provided below:
| September 30, 2025 | December 31, 2024 | |||||||
|---|---|---|---|---|---|---|---|---|
| Long-lived assets: | ||||||||
| U.S. | $ | 2,404.7 | $ | 2,303.1 | ||||
| U.K. | 655.0 | 589.4 | ||||||
| Other countries | 487.1 | 460.6 | ||||||
| Total long-lived assets | $ | 3,546.8 | $ | 3,353.1 |
23
We consider our stockholders that own more than 5.0% of the outstanding stock within the class to be related parties as defined within ASC 850, Related Party Disclosures. For the nine months ended September 30, 2025 and 2024, we had no material transactions with related parties owning more than 5.0% of the entire class of stock.
24
15. Commitments and Contingencies:
We are a party to legal proceedings, investigations, examinations, subpoenas, third party requests, government requests, regulatory proceedings and other claims with respect to a variety of matters in the ordinary course of business, including the matters described below (collectively, “Ongoing Matters”). With respect to Ongoing Matters, we are unable, at the present time, to determine the ultimate resolution of or provide a reasonable estimate of the range of possible loss attributable to Ongoing Matters or the impact these matters may have on our results of operations, financial position, or cash flows. Although we believe we have strong defenses and have appealed adverse rulings to us, we could in the future incur judgments or enter into settlements of claims that could have a material adverse effect on our results of operations, financial position, or cash flows.
Telematics Litigation
As of April 19, 2024, various Plaintiffs filed a total of twenty separate putative class action lawsuits, sixteen against General Motors LLC (“GM”), OnStar LLC (“OnStar”), LexisNexis Risk Solutions, Inc. (“LexisNexis”) and Verisk Analytics Inc. in the United States District Courts for the Northern District of Georgia, the Eastern District of Michigan, Central District of California, District of New Jersey, Southern District of New York, Northern District of Alabama, Northern District of Illinois and District of South Carolina, and four against Hyundai Motor America (“Hyundai”) and Verisk in the Central District of California and District of New Jersey, all of which have been dismissed to date. The Complaints generally allege that the auto manufacturer Defendants collected consumers’ driver behavior data through vehicle software, transmitted it to LexisNexis and Verisk, and that LexisNexis and Verisk shared the data with auto insurance companies, without the individuals’ knowledge or consent. Plaintiffs seek certification of both nationwide classes of individuals and subclasses of various state residents who had their vehicle’s driving data collected by Defendants and shared with a third party without their consent. The Plaintiffs also seek actual, statutory and punitive damages, injunctive relief, as well as reasonable attorney’s fees and other costs. On June 7, the Judicial Panel on Multidistrict Litigation transferred all GM-related lawsuits to the U.S. District Court for the Northern District of Georgia (In Re: Consumer Vehicle Driving Data Tracking Litigation, MDL Case No. 1:24-md-03115-TWT_)_. All discovery proceedings have been stayed. The matters pending against Verisk in the MDL were voluntarily dismissed on December 13, 2024, and a new putative class action, Adam Dinitz, et al. v. Verisk Analytics, Inc. (“Dinitz”), was filed in the District of New Jersey federal court, Case No. 24-11157, to include those dismissed matters and additional named Plaintiffs. Dinitz was transferred to the Northern District of Georgia to be part of the consolidated MDL. A related amended Master Consolidated class action Complaint was also filed in the MDL on December 13, 2024. Defendants filed their motions to dismiss Plaintiffs' claims on April 14, 2025. On October 2, 2025, several Plaintiffs brought a lawsuit alleging similar claims against GM, OnStar, LexisNexis, and Verisk in the matter, McBride, et al v. General Motors, et al., in the U.S. District Court, Southern District of California, Case No. 3:25-cv-02619-AJB-MMP. At this time, it is not possible to reasonably estimate the liability related to these and other associated matters, as they are still in their early stages.
Indemnification Claim
In December 2023, we received a Notice of Indemnification claim from the current owner of our former healthcare data analytics subsidiary, which was divested in 2016, relating to an ongoing tax investigation by the Nepalese tax authorities. Pursuant to the 2016 sale agreement, we are subject to indemnification obligations with respect to certain pre-closing tax liabilities of the divested entity. At this time, it is not possible to reasonably estimate the liability related to this matter, as it is still in its early stages.
Commercial Litigation
On February 12, 2024, Plaintiffs filed a lawsuit, DDS Striker Holdings LLC and Data Driven Holdings LLC against Verisk Analytics, Inc. and Insurance Service Office, in the Superior Court of Delaware, Case No. N24C-02-130 VLM CCLD. Plaintiffs allege claims for breach of contract, breach of the implied covenant of good faith and fair dealing, fraudulent inducement, common law fraud, and civil conspiracy in connection with their inability to meet the post-closing earn-out targets negotiated as part of our acquisition of Data Driven Safety, LLC. Plaintiffs seek rescissory, out-of-pocket and punitive damages, as well as attorney’s fees, costs and other expenses. We filed a motion to dismiss Plaintiffs’ claims, which was fully briefed as of June 21, 2024, and was partially denied on August 29, 2024. Discovery is ongoing. At this time, it is not possible to reasonably estimate the liability related to this matter, as the case is still in its early stages.
Data Privacy Litigation
On or about February 8, 2023, Plaintiffs filed a lawsuit, Atlas Data Privacy Corp., et al. v. Verisk Analytics, Inc., et al., in the Superior Court of New Jersey, Middlesex County, Case No. MID-L-000903-24, alleging violations of Daniel’s Law. Atlas claims to be an “assignee” of claims of approximately 19,640 individuals who are “covered persons” under Daniel’s Law, allegedly enacted to provide judicial and law enforcement officers and their family members with the right to prevent disclosure of their personal information and to enforce those rights against uncooperative data brokers. It is alleged that Defendants have violated Daniel’s Law by failing to respond and comply with their written request to Defendants to cease publicly disclosing or re-disclosing their protected information. Plaintiffs seek actual damages in the amount of $1,000 per violation under the statute, punitive damages, injunctive relief ordering compliance with Daniel’s Law, permanent injunctive relief, including the appointment of a qualified independent expert to ensure compliance with Daniel’s Law, and reasonable attorney’s fees and costs. On June 21, 2024, the court issued a “lack of prosecution” warning to Atlas, advising that the case will be dismissed without prejudice if service is not effectuated by August 20, 2024. The case was dismissed without prejudice on August 26, 2024. On October 11, 2024, Plaintiffs served Verisk with the Summons and Complaint, indicating their intent to revise the lawsuit. We filed a motion to dismiss, and alternatively, a request to stay the case pending a ruling on constitutionality of Daniel's Law by the 3rd Circuit in a separate Atlas lawsuit. The New Jersey Attorney General’s Office moved to intervene and also sought a stay pending a constitutionality decision by the New Jersey Supreme Court in a separate matter. The court issued an Order staying all discovery until further ordered by the court. At this time, it is not possible to reasonably estimate the liability related to this matter, as the case is still in its early stages.
25
16. Subsequent Events:
On July 29, 2025, we entered into a definitive agreement to acquire AccuLynx for $2.35 billion in cash to augment our network capabilities across the insurance claims and restoration ecosystem. AccuLynx is the leading SaaS platform providing end-to-end business management workflow for residential property contractors with expertise in roofing. On October 22, 2025, we and AccuLynx each received a Request for Additional Information and Documentary Material (Second Request) from the U.S. Federal Trade Commission as part of the agency’s review of the proposed transaction. Upon the satisfaction of customary closing conditions including regulatory approval, AccuLynx will become part of property estimating solutions within our insurance segment.
26
Previous: Cover and table of contents · Next: Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations